| NCT ID | NCT06359301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Limacorporate S.p.a |
| Condition | Hip, Osteoarthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 49 participants |
| Start Date | 2021-09-14 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 49 participants in total. It began in 2021-09-14 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup.
Eligibility Criteria
Inclusion Criteria: * male or female in whom a decision has already been made to perform a total hip arthroplasty with DELTA Revision acetabular cup as per indication for use. The decision to implant DELTA revision acetabular cup must be taken prior to, and independently from the decision to enroll the patient. This decision should be made in accorsance with routine clinical practice at the study site concerned. * Age ≥ 18 years old * All patients mist give written informed consent approved by the study site's Institutinal Review Board (IRB)/Ethical Committee (EC) * Patient is able to comply with the protocol Exclusion Criteria: * Adult patients with any DELTA Revision acetabular cup contraindication for use as reported in the current local instruction for use. * For female patiens, current pregnancy and/or lactation or planning a pregnancy
Contact & Investigator
Jerzy Bialecki
PRINCIPAL INVESTIGATOR
Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP
Frequently Asked Questions
Who can join the NCT06359301 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip, Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06359301 currently recruiting?
Yes, NCT06359301 is actively recruiting participants. Contact the research team at federica.azzimonti@limacorporate.com for enrollment information.
Where is the NCT06359301 trial being conducted?
This trial is being conducted at Otwock, Poland.
Who is sponsoring the NCT06359301 clinical trial?
NCT06359301 is sponsored by Limacorporate S.p.a. The principal investigator is Jerzy Bialecki at Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP. The trial plans to enroll 49 participants.